Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses.

Br J Psychiatry · 2025 · PMC12038388 · PMID 39428384

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantP = 0.05actually significant

However, data indicated a borderline significant subgroup differences ( P = 0.05) between subgroups of trials that excluded participants with PTSD and those that did not: a numerically larger treatment effect was observed in the trials that excluded PTSD (SMD −0.32, 95% CI −0.60 to −0.03) versus those that did not exclude PTSD (SMD 0.02, 95% CI −0.15 to 0.18).

also in 7,848 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.